Amphastar Pharmaceuticals, Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $98.0M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $27.5M | 28.0% |
| Other Investing | $1.2M | 1.2% |
| Stock Repurchases | $0 | 0.0% |
| Other Financing | $0 | 0.0% |
| Other | $37.2M | 38.0% |
| Net Cash Flow | $32.1M | 32.7% |